Clinical Trial Update: Trichuris Suis Ova Treatment in Left-sided Ulcerative Colitis [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating Trichuris suis ova for left-sided ulcerative colitis; the study was terminated with results posted in 2017.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ulcerative Colitis

Drugs mentioned

• Trichuris suis ova (Trichuris suis ova)

Snippet

Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) | Conditions: Colitis, Ulcerative | Phase 2 | Status: TERMINATED | Results posted: 2017-02-10